CLOVER HEALTH INVESTMENTS, CORP. /DE Cash and Cash Equivalents
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) had Cash and Cash Equivalents of $78.30 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-02-27
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $78.30M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $194.54M.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $287.96M.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $254.77M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-12-31 | $78.30M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $194.54M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $287.96M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $254.77M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $208.25M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $122.86M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $299.01M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $310.08M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $190.56M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $103.79M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $382.87M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $324.47M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $273.83M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $299.97M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $202.26M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $485.75M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $404.51M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $92.35M 10-K · filed 2023-03-01 | $28.00M 10-K · filed 2021-03-31 |
| 2020-09-30 | $126.75K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $750.54K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $112.49M 10-Q · filed 2021-05-17 | $63.37K 10-Q · filed 2020-06-04 |
| 2019-12-31 | $67.60M 10-Q · filed 2021-05-17 | $0.00 10-Q · filed 2020-06-04 |